skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Do you consider that today's news of a joint agreement with Astra Seneca is significant enough to open a full position in Fusion? My read is that the agreement confirms that AZ believes FUSION has the goods so to speak, and is relieving them of a huge part of the costs of development in exchange for a piece of the action. I like the deal but would like your opinion before I jump.
John
Read Answer Asked by JOHN on November 03, 2020
Q: HI 5i Team,
In my USD account I hold REGN and ABBV @ 3.5%. I am considering adding ALXN growth. What is your opinion of this stock? If not this then any alternative? Dividends are not a priority.
Over the last 3 year of my membership, have immensely benefitted from your advice. Keep up the good work.
RR
Read Answer Asked by Rajinder on November 02, 2020
Q: I would like to own WELL. My hesitation is what you identify under Key Risks in your report - "inability to compete with larger players such as Telus and Loblaw in the digital health care solutions space ".
I own both Telus and Loblaw and recognize that their exposure to digital health space is a small part of their over-all business at this point while WELL is the pure play growth option.
Having difficulty assessing this and would appreciate your thoughts.
Not asking for specific portfolio advice , but just in broad , general terms -
if one owns these two larger companies , would it be appropriate to put Well in the "like to own " rather than "need to own " category and allocate capital elsewhere .
Thank-you
Read Answer Asked by William on November 02, 2020
Q: Hi,
is the current debt level for ABBV to risky in the current economic environment or is the projected cash flow enough to reduce this risk? Might this cause dividend increases in the future not to happen?
In some of your answers to questions from members regarding health care stocks in the US, you often mention the election as a possible concern. Could you expand on this please? I assume you mean that one party is better than the other for this sector.
Thanks,
Dan
Read Answer Asked by Daniel on November 02, 2020
Q: RE; Healthcare,
I currently have a limited amount of healthcare exposure in my portfolio and looking to build the allocation. I hold some MDT in my US account, I have been adding to that holding on dips. I would appreciate hearing your favourite US and Canadian healthcare stocks.. Please provide your top choices for US and Canada plus any particular ETF's you like in the healthcare sector. Thank you, Patrick
Read Answer Asked by Patrick on November 02, 2020
Q: Hello Peter,
I would like your assessment of DXCM after the earnings call. The growth rate has not tapered, the valuation on P/E and P/B looks to be in line with growth companies such as CRWD, VEEV etc. The product has now access to the european market, which probably was not part of the equation earlier quarter. Apart from the impending retirement of a senior executive, what would cause the sharp drop relative to the market?
Would this be a candidate for capital loss sale and buy in Dec or Jan?
Look forward to your thoughts.
Regards
Rajiv
Read Answer Asked by Rajiv on October 29, 2020
Q: Your answer to Jo-Anne's question this morning about Reliq's contract announcement seems fair (another 'good' contract but previous one's haven't translated into much revenue).

However, there was a 2nd simultaneous press release regarding a 'Non-Brokered Private Placement' in which they announce their on-boarding partners (one of them being the new contract announcement this morning) have invested in the company. At first a raise at the low share price seems negative but when your clients invest in your company, you would think they'd be motivated to onboard patients to increase revenue. Does this drastically change the risk/reward for an investor in RHT?
Read Answer Asked by Brent on October 28, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!